grant

Cell cycle and checkpoint variations in development and disease

Organization TRUSTEES OF INDIANA UNIVERSITYLocation BLOOMINGTON, UNITED STATESPosted 5 Jul 2024Deadline 31 May 2029
NIHUS FederalResearch GrantFY2025AddressAffectAntioncogene Protein p53ApoptoticBiologic ModelsBiological ModelsBody TissuesCancer InductionCancer TreatmentCancersCell BodyCell Culture TechniquesCell CycleCell Cycle ControlCell Cycle RegulationCell Division CycleCell FunctionCell PhysiologyCell ProcessCellsCellular FunctionCellular PhysiologyCellular ProcessCellular Tumor Antigen P53ClinicCommentCommentaryCompetenceDNA DamageDNA InjuryDevelopmentDevelopmental TherapeuticsDevelopmental Therapeutics ProgramDevelopmental TherapyDiagnosisDiseaseDisorderDrosophilaDrosophila genusDrosophila melanogasterEditorial CommentGene Down-RegulationGeneralized GrowthGenomic approachGrowthHealthHumanInvestigationIsoformsKnowledgeM PhaseMalignant Neoplasm TherapyMalignant Neoplasm TreatmentMalignant NeoplasmsMalignant TumorMitosisMitosis StageMitoticModel SystemModelingModern ManMolecularNewly DiagnosedOncogenesisOncoprotein p53OrganismOutcomeP53Pathway interactionsPhosphoprotein P53Phosphoprotein pp53PolyploidPolyploid CellsPolyploidyProcessPropertyProtein IsoformsProtein TP53Published CommentRelapseRepressionResistanceSignal PathwayStressSubcellular ProcessTP53TP53 geneTRP53Tissue GrowthTissuesTranscription RepressionTumor Protein p53Tumor Protein p53 GeneVariantVariationViewpointanti-cancer therapybiological adaptation to stresscancer therapycancer-directed therapycarcinogenesiscell culturecell culturescell typedevelopmentalfruit flygene repressiongenome integritygenomic effortgenomic integritygenomic strategyin vivoliving systemmalformationmalignancyneoplasm/cancernew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generation therapeuticsnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapyontogenyp53 Antigenp53 Genesp53 Tumor Suppressorpathwayprogramsprotein p53reaction; crisisregenerate new tissueregenerate tissueregenerating damaged tissueregenerating tissueresistantresponsestress responsestress; reactiontissue regenerationtissue regrowthtissue renewaltissue specific regenerationtumorigenesis
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Project Summary
The Calvi lab investigates the regulation of cell cycle and genome integrity using Drosophila melanogaster as a

model system. Our ongoing studies are defining the variations in cell cycle and checkpoints in development

and how these variations are related to disease. One cell cycle variant that we have focused on is called the…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Cell cycle and checkpoint variations in development and disease — TRUSTEES OF INDIANA UNIVERSITY | UNITED STATES | Jul 2 | Dev Procure